{"id": "article-25834_0", "title": "Neurosarcoidosis -- Continuing Education Activity", "content": "Sarcoidosis is a systemic disease that results in the formation of granulomas which classically are non-caseating granulomas, that may be found throughout lymph nodes and organs, including the brain and nervous system. About 5 to 10 percent of patients with sarcoidosis will have neurologic complications. Neurosarcoidosis may be asymptomatic but can be life-threatening and tends to occur in cases with systemic involvement. This activity examines when this condition should be considered on differential diagnosis and how to properly evaluate for it. This activity highlights the role of the interprofessional team in caring for patients with this condition.", "contents": "Neurosarcoidosis -- Continuing Education Activity. Sarcoidosis is a systemic disease that results in the formation of granulomas which classically are non-caseating granulomas, that may be found throughout lymph nodes and organs, including the brain and nervous system. About 5 to 10 percent of patients with sarcoidosis will have neurologic complications. Neurosarcoidosis may be asymptomatic but can be life-threatening and tends to occur in cases with systemic involvement. This activity examines when this condition should be considered on differential diagnosis and how to properly evaluate for it. This activity highlights the role of the interprofessional team in caring for patients with this condition."}
{"id": "article-25834_1", "title": "Neurosarcoidosis -- Continuing Education Activity", "content": "Objectives: Describe the common presenting features of neurosarcoidosis. Review how to properly evaluate for neurosarcoidosis. Outline the management of neurosarcoidosis. Explain how an interprofessional approach is imperative to the effective management of patients with neurosarcoidosis. Access free multiple choice questions on this topic.", "contents": "Neurosarcoidosis -- Continuing Education Activity. Objectives: Describe the common presenting features of neurosarcoidosis. Review how to properly evaluate for neurosarcoidosis. Outline the management of neurosarcoidosis. Explain how an interprofessional approach is imperative to the effective management of patients with neurosarcoidosis. Access free multiple choice questions on this topic."}
{"id": "article-25834_2", "title": "Neurosarcoidosis -- Introduction", "content": "Although the etiology is unknown, sarcoidosis is a systemic disease that results in the formation of granulomas. Classically, the granulomas in sarcoidosis are non-caseating granulomas,\u00a0which may be found\u00a0throughout lymph nodes and organs, including the brain and nervous system. About 5% to 10% of patients with sarcoidosis will have neurologic complications. [1] [2] Although\u00a0the majority of\u00a0patients with sarcoidosis do not have symptoms,\u00a0neurosarcoidosis\u00a0may be life-threatening and\u00a0tends to occur\u00a0in cases with systemic involvement.", "contents": "Neurosarcoidosis -- Introduction. Although the etiology is unknown, sarcoidosis is a systemic disease that results in the formation of granulomas. Classically, the granulomas in sarcoidosis are non-caseating granulomas,\u00a0which may be found\u00a0throughout lymph nodes and organs, including the brain and nervous system. About 5% to 10% of patients with sarcoidosis will have neurologic complications. [1] [2] Although\u00a0the majority of\u00a0patients with sarcoidosis do not have symptoms,\u00a0neurosarcoidosis\u00a0may be life-threatening and\u00a0tends to occur\u00a0in cases with systemic involvement."}
{"id": "article-25834_3", "title": "Neurosarcoidosis -- Introduction", "content": "Neurosarcoidosis tends to occur in patients who have systemic features and active disease. The diagnosis of neurosarcoidosis is difficult and usually one of exclusion. Sometimes a nerve or muscle biopsy may reveal a non-caseating granuloma. There is no cure for neurosarcoidosis. Most patients require long-term treatment with corticosteroids.", "contents": "Neurosarcoidosis -- Introduction. Neurosarcoidosis tends to occur in patients who have systemic features and active disease. The diagnosis of neurosarcoidosis is difficult and usually one of exclusion. Sometimes a nerve or muscle biopsy may reveal a non-caseating granuloma. There is no cure for neurosarcoidosis. Most patients require long-term treatment with corticosteroids."}
{"id": "article-25834_4", "title": "Neurosarcoidosis -- Etiology", "content": "Although the cause is unclear,\u00a0sarcoidosis is believed\u00a0to be a hyperactive immune response. Th1 cells stimulate the release of IL-2 and IFN-gamma which then activate macrophages.\u00a0In turn, the\u00a0inflammatory response induced by macrophages causes granuloma formation. The most common neurological abnormalities reported include the following: Papilledema Cranial neuropathies Peripheral neuropathy Myopathy and mononeuropathy Neuropsychiatric disturbances Ataxia Hydrocephalus", "contents": "Neurosarcoidosis -- Etiology. Although the cause is unclear,\u00a0sarcoidosis is believed\u00a0to be a hyperactive immune response. Th1 cells stimulate the release of IL-2 and IFN-gamma which then activate macrophages.\u00a0In turn, the\u00a0inflammatory response induced by macrophages causes granuloma formation. The most common neurological abnormalities reported include the following: Papilledema Cranial neuropathies Peripheral neuropathy Myopathy and mononeuropathy Neuropsychiatric disturbances Ataxia Hydrocephalus"}
{"id": "article-25834_5", "title": "Neurosarcoidosis -- Epidemiology", "content": "The prevalence of sarcoidosis has been estimated\u00a0to be about 152 to 215 per 100,000. [3] About 5 to 10% of patients with sarcoidosis will have neurologic complications. [1] Regarding race,\u00a0neurosarcoidosis\u00a0has\u00a0been documented\u00a0more commonly within Africans and African descent. [4] However, about half of patients with sarcoidosis have systemic disease, with 30% to 70% who have concomitant neurologic signs when first diagnosed. The condition is rare in children.", "contents": "Neurosarcoidosis -- Epidemiology. The prevalence of sarcoidosis has been estimated\u00a0to be about 152 to 215 per 100,000. [3] About 5 to 10% of patients with sarcoidosis will have neurologic complications. [1] Regarding race,\u00a0neurosarcoidosis\u00a0has\u00a0been documented\u00a0more commonly within Africans and African descent. [4] However, about half of patients with sarcoidosis have systemic disease, with 30% to 70% who have concomitant neurologic signs when first diagnosed. The condition is rare in children."}
{"id": "article-25834_6", "title": "Neurosarcoidosis -- Pathophysiology", "content": "A variety of theories have been used\u00a0to explain the etiology of\u00a0neurosarcoidosis. Sarcoidosis affects the lymphoreticular system, characterized by cervical and mediastinal lymphadenopathy.\u00a0 Due to\u00a0the distribution of lymphatics, the spleen and liver can also\u00a0be\u00a0affected.\u00a0Neurosarcoidosis\u00a0results from sarcoid granulomas within the nervous system. Pathologically, lymphocytes and mononuclear phagocytes surround a noncaseating epithelioid cell granuloma. Symptoms result from the location of where the granulomas lie in the nervous system. For example, granulomas in the muscle may cause myositis, while granulomas in the nerve within the perineurium and epineurium may cause axonal damage and as a result peripheral neuropathy. Nerve injury may cause diffuse polyneuropathy,\u00a0mononeuritis\u00a0multiplex, and polyradiculopathy\u00a0due to spinal root sheath involvement.", "contents": "Neurosarcoidosis -- Pathophysiology. A variety of theories have been used\u00a0to explain the etiology of\u00a0neurosarcoidosis. Sarcoidosis affects the lymphoreticular system, characterized by cervical and mediastinal lymphadenopathy.\u00a0 Due to\u00a0the distribution of lymphatics, the spleen and liver can also\u00a0be\u00a0affected.\u00a0Neurosarcoidosis\u00a0results from sarcoid granulomas within the nervous system. Pathologically, lymphocytes and mononuclear phagocytes surround a noncaseating epithelioid cell granuloma. Symptoms result from the location of where the granulomas lie in the nervous system. For example, granulomas in the muscle may cause myositis, while granulomas in the nerve within the perineurium and epineurium may cause axonal damage and as a result peripheral neuropathy. Nerve injury may cause diffuse polyneuropathy,\u00a0mononeuritis\u00a0multiplex, and polyradiculopathy\u00a0due to spinal root sheath involvement."}
{"id": "article-25834_7", "title": "Neurosarcoidosis -- Histopathology", "content": "The classical finding of sarcoidosis is noncaseating granulomas. Nerve biopsies\u00a0demonstrate\u00a0axonal degeneration with nerve atrophy.\u00a0Myelin ovoids may be seen\u00a0as a sign of demyelination. [5]", "contents": "Neurosarcoidosis -- Histopathology. The classical finding of sarcoidosis is noncaseating granulomas. Nerve biopsies\u00a0demonstrate\u00a0axonal degeneration with nerve atrophy.\u00a0Myelin ovoids may be seen\u00a0as a sign of demyelination. [5]"}
{"id": "article-25834_8", "title": "Neurosarcoidosis -- History and Physical", "content": "Common features of central or peripheral nervous system involvement include cranial mononeuropathy involving the facial nerve, neuroendocrine dysfunction involving the hypothalamus (i.e. neurogenic diabetes insipidus), myelopathy or radiculopathy if the spinal cord\u00a0is affected\u00a0(in rare cases cauda equina\u00a0polyradiculopathy\u00a0may occur), hydrocephalus, meningitis, mononeuropathy,\u00a0mononeuritis\u00a0multiplex, carpal tunnel, and muscle involvement which may cause proximal myopathy and muscle atrophy. Symptoms of\u00a0neurosarcoidosis\u00a0may be multifocal, commonly seen first in the cranial nerves. The facial nerve is the most common cranial nerve affected, which may mimic Lyme disease.\u00a0Heerfordt\u00a0syndrome is a rare manifestation of\u00a0neurosarcoidosis\u00a0which presents with facial nerve palsy and\u00a0the presence of\u00a0parotid gland enlargement, anterior uveitis, and fever. [6] Carpal tunnel may also be more frequent in sarcoidosis patients than in the rest of the population. [7] Another cranial nerve that may\u00a0be affected\u00a0is the\u00a0vestibulocochlear\u00a0nerve causing balance and hearing problems. [8] Cerebellar signs, such as ataxia, may be present with cerebellar involvement. [9] During the exam, it is important to assess for papilledema and mental status as psychiatric abnormalities may also occur.\u00a0Chronic meningitis with basal meningeal involvement is a common manifestation of neurosarcoidosis. Meningitis may present with either leptomeningeal or pachymeningeal involvement. It is one of the several important causes of pachymeningitis.", "contents": "Neurosarcoidosis -- History and Physical. Common features of central or peripheral nervous system involvement include cranial mononeuropathy involving the facial nerve, neuroendocrine dysfunction involving the hypothalamus (i.e. neurogenic diabetes insipidus), myelopathy or radiculopathy if the spinal cord\u00a0is affected\u00a0(in rare cases cauda equina\u00a0polyradiculopathy\u00a0may occur), hydrocephalus, meningitis, mononeuropathy,\u00a0mononeuritis\u00a0multiplex, carpal tunnel, and muscle involvement which may cause proximal myopathy and muscle atrophy. Symptoms of\u00a0neurosarcoidosis\u00a0may be multifocal, commonly seen first in the cranial nerves. The facial nerve is the most common cranial nerve affected, which may mimic Lyme disease.\u00a0Heerfordt\u00a0syndrome is a rare manifestation of\u00a0neurosarcoidosis\u00a0which presents with facial nerve palsy and\u00a0the presence of\u00a0parotid gland enlargement, anterior uveitis, and fever. [6] Carpal tunnel may also be more frequent in sarcoidosis patients than in the rest of the population. [7] Another cranial nerve that may\u00a0be affected\u00a0is the\u00a0vestibulocochlear\u00a0nerve causing balance and hearing problems. [8] Cerebellar signs, such as ataxia, may be present with cerebellar involvement. [9] During the exam, it is important to assess for papilledema and mental status as psychiatric abnormalities may also occur.\u00a0Chronic meningitis with basal meningeal involvement is a common manifestation of neurosarcoidosis. Meningitis may present with either leptomeningeal or pachymeningeal involvement. It is one of the several important causes of pachymeningitis."}
{"id": "article-25834_9", "title": "Neurosarcoidosis -- History and Physical", "content": "In gathering a history, the first sign of\u00a0neurosarcoidosis\u00a0may be seizures, which\u00a0generally\u00a0confers a poor prognosis. Patients with simple partial or complex partial seizures may have a better prognosis\u00a0in comparison\u00a0to generalized tonic-clonic seizures. Depending on the location of the disease in the brain, the patient may also present with: Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) Changes in appetite Somnolence Autonomic impairment Weight gain Impotence Galactorrhea Dementia Impaired cognition", "contents": "Neurosarcoidosis -- History and Physical. In gathering a history, the first sign of\u00a0neurosarcoidosis\u00a0may be seizures, which\u00a0generally\u00a0confers a poor prognosis. Patients with simple partial or complex partial seizures may have a better prognosis\u00a0in comparison\u00a0to generalized tonic-clonic seizures. Depending on the location of the disease in the brain, the patient may also present with: Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) Changes in appetite Somnolence Autonomic impairment Weight gain Impotence Galactorrhea Dementia Impaired cognition"}
{"id": "article-25834_10", "title": "Neurosarcoidosis -- Evaluation", "content": "Neurosarcoidosis\u00a0should be\u00a0considered\u00a0in patients with sarcoidosis who develop neurologic abnormalities. However, the index of suspicion is lower and thus much more difficult\u00a0in cases\u00a0where a patient\u00a0is not known\u00a0to have sarcoid but has neurologic abnormalities.\u00a0Unfortunately, there is no diagnostic marker for\u00a0neurosarcoidosis.", "contents": "Neurosarcoidosis -- Evaluation. Neurosarcoidosis\u00a0should be\u00a0considered\u00a0in patients with sarcoidosis who develop neurologic abnormalities. However, the index of suspicion is lower and thus much more difficult\u00a0in cases\u00a0where a patient\u00a0is not known\u00a0to have sarcoid but has neurologic abnormalities.\u00a0Unfortunately, there is no diagnostic marker for\u00a0neurosarcoidosis."}
{"id": "article-25834_11", "title": "Neurosarcoidosis -- Evaluation", "content": "If\u00a0neurosarcoidosis\u00a0is\u00a0suspected, it\u00a0is important to assess for signs of systemic\u00a0diseases, such as the skin, lymph nodes, and lungs. Tests to conduct include\u00a0ophthalmologic exam (including optical coherence tomography), nasal/sinus examination, chest x-ray (for\u00a0perihilar\u00a0lymphadenopathy), angiotensin-converting enzyme (ACE) assay (not specific), and in rare cases a magnetic resonance, gallium or\u00a0fluorodeoxyglucose\u00a0emission tomographic scan for areas of inflammation that may\u00a0be biopsied.", "contents": "Neurosarcoidosis -- Evaluation. If\u00a0neurosarcoidosis\u00a0is\u00a0suspected, it\u00a0is important to assess for signs of systemic\u00a0diseases, such as the skin, lymph nodes, and lungs. Tests to conduct include\u00a0ophthalmologic exam (including optical coherence tomography), nasal/sinus examination, chest x-ray (for\u00a0perihilar\u00a0lymphadenopathy), angiotensin-converting enzyme (ACE) assay (not specific), and in rare cases a magnetic resonance, gallium or\u00a0fluorodeoxyglucose\u00a0emission tomographic scan for areas of inflammation that may\u00a0be biopsied."}
{"id": "article-25834_12", "title": "Neurosarcoidosis -- Evaluation", "content": "In\u00a0evaluating\u00a0peripheral neuropathy, it is important to rule out other common causes of neuropathy such as hyperglycemic states, vitamin deficiencies, kidney failure, and toxins.\u00a0Thermal threshold testing may be used\u00a0for small-fiber neuropathy.", "contents": "Neurosarcoidosis -- Evaluation. In\u00a0evaluating\u00a0peripheral neuropathy, it is important to rule out other common causes of neuropathy such as hyperglycemic states, vitamin deficiencies, kidney failure, and toxins.\u00a0Thermal threshold testing may be used\u00a0for small-fiber neuropathy."}
{"id": "article-25834_13", "title": "Neurosarcoidosis -- Evaluation", "content": "Neurodiagnostic\u00a0tests may help rule out other differentials such as infection and malignancy. The imaging of choice is a\u00a0contrast-enhanced\u00a0MRI. Typical findings are basal meningeal enhancement especially with contrast-enhancing lesions involving the hypothalamus, pituitary stalk, and adjacent tissues. (See MRI below). Gadolinium and\u00a0fluid-attenuated\u00a0inversion recovery (FLAIR) are helpful to identify T2 enhancement of nerve roots, plexuses, and nerves.\u00a0Active inflammation may be seen\u00a0with meningeal or parenchymal enhancement.\u00a0Parenchymal, meningeal masses, and hydrocephalus may also be seen\u00a0with MRI.", "contents": "Neurosarcoidosis -- Evaluation. Neurodiagnostic\u00a0tests may help rule out other differentials such as infection and malignancy. The imaging of choice is a\u00a0contrast-enhanced\u00a0MRI. Typical findings are basal meningeal enhancement especially with contrast-enhancing lesions involving the hypothalamus, pituitary stalk, and adjacent tissues. (See MRI below). Gadolinium and\u00a0fluid-attenuated\u00a0inversion recovery (FLAIR) are helpful to identify T2 enhancement of nerve roots, plexuses, and nerves.\u00a0Active inflammation may be seen\u00a0with meningeal or parenchymal enhancement.\u00a0Parenchymal, meningeal masses, and hydrocephalus may also be seen\u00a0with MRI."}
{"id": "article-25834_14", "title": "Neurosarcoidosis -- Evaluation", "content": "As with other inflammatory states,\u00a0ESR may be elevated.\u00a0Creatinine kinase and aldolase may also be used\u00a0to evaluate for myopathy. Liver function testing may also be abnormal,\u00a0thereby\u00a0reflecting the systemic involvement of sarcoidosis.\u00a0If\u00a0the pituitary-hypothalamic axis is affected,\u00a0endocrine studies should be done. In recent years, F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging has been used to evaluate for neurosarcoidosis. F-18 FDG PET/CT is gaining popularity in patients with suspected systemic sarcoidosis, especially with pulmonary or cardiac involvement. It can provide valuable information to the site of involvement by the disease and the selection of more surgically accessible sites for biopsy.", "contents": "Neurosarcoidosis -- Evaluation. As with other inflammatory states,\u00a0ESR may be elevated.\u00a0Creatinine kinase and aldolase may also be used\u00a0to evaluate for myopathy. Liver function testing may also be abnormal,\u00a0thereby\u00a0reflecting the systemic involvement of sarcoidosis.\u00a0If\u00a0the pituitary-hypothalamic axis is affected,\u00a0endocrine studies should be done. In recent years, F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging has been used to evaluate for neurosarcoidosis. F-18 FDG PET/CT is gaining popularity in patients with suspected systemic sarcoidosis, especially with pulmonary or cardiac involvement. It can provide valuable information to the site of involvement by the disease and the selection of more surgically accessible sites for biopsy."}
{"id": "article-25834_15", "title": "Neurosarcoidosis -- Evaluation", "content": "If the diagnosis remains uncertain, biopsies of the meninges, brain, or spinal cord may be\u00a0indicated. [10] However, biopsies of the skin, lymph node, and\u00a0lung are less risky and thus, are more preferred.\u00a0A biopsy\u00a0may also be considered\u00a0for patients who do not respond to therapy.", "contents": "Neurosarcoidosis -- Evaluation. If the diagnosis remains uncertain, biopsies of the meninges, brain, or spinal cord may be\u00a0indicated. [10] However, biopsies of the skin, lymph node, and\u00a0lung are less risky and thus, are more preferred.\u00a0A biopsy\u00a0may also be considered\u00a0for patients who do not respond to therapy."}
{"id": "article-25834_16", "title": "Neurosarcoidosis -- Treatment / Management", "content": "Given the inflammatory process, corticosteroids are the main treatment for neural sarcoidosis. For facial nerve palsy or aseptic meningitis, prednisone\u00a0is given\u00a0every day for 2 weeks usually. In cases of meningeal, parenchymal mass lesion, or myopathy or\u00a0neuropathy, prednisone should be given\u00a0for at least 4 weeks. For deteriorating patients, intravenous (IV) methylprednisolone is given\u00a0for 3 days followed by prednisone for 2 to 4 weeks.\u00a0The steroid dose should be tapered\u00a0over several months with follow-up by a neurologist every 3 to 6 months. Immunosuppressants\u00a0may also be considered, such as cyclosporine, methotrexate, and cyclophosphamide. Low dose radiation is often given to patients in who steroids fail to work. Other treatments include: Hormone replacement if there is hypopituitarism Antipsychotics for behavior control and psychosis Support for dementia Recently tumor necrosis factor antagonists have been tried with partial improvement.", "contents": "Neurosarcoidosis -- Treatment / Management. Given the inflammatory process, corticosteroids are the main treatment for neural sarcoidosis. For facial nerve palsy or aseptic meningitis, prednisone\u00a0is given\u00a0every day for 2 weeks usually. In cases of meningeal, parenchymal mass lesion, or myopathy or\u00a0neuropathy, prednisone should be given\u00a0for at least 4 weeks. For deteriorating patients, intravenous (IV) methylprednisolone is given\u00a0for 3 days followed by prednisone for 2 to 4 weeks.\u00a0The steroid dose should be tapered\u00a0over several months with follow-up by a neurologist every 3 to 6 months. Immunosuppressants\u00a0may also be considered, such as cyclosporine, methotrexate, and cyclophosphamide. Low dose radiation is often given to patients in who steroids fail to work. Other treatments include: Hormone replacement if there is hypopituitarism Antipsychotics for behavior control and psychosis Support for dementia Recently tumor necrosis factor antagonists have been tried with partial improvement."}
{"id": "article-25834_17", "title": "Neurosarcoidosis -- Differential Diagnosis", "content": "Other differentials to consider for\u00a0neurosarcoidosis\u00a0include primary brain tumors, toxin ingestion, neuropathies secondary to monoclonal proliferation or\u00a0paraproteinemic\u00a0neuropathy, paraneoplastic neuropathy, vitamin deficiency, leptomeningeal carcinomatosis, multiple sclerosis, central nervous system (CNS) lymphoma, or autoimmune conditions like systemic lupus erythematosus.", "contents": "Neurosarcoidosis -- Differential Diagnosis. Other differentials to consider for\u00a0neurosarcoidosis\u00a0include primary brain tumors, toxin ingestion, neuropathies secondary to monoclonal proliferation or\u00a0paraproteinemic\u00a0neuropathy, paraneoplastic neuropathy, vitamin deficiency, leptomeningeal carcinomatosis, multiple sclerosis, central nervous system (CNS) lymphoma, or autoimmune conditions like systemic lupus erythematosus."}
{"id": "article-25834_18", "title": "Neurosarcoidosis -- Prognosis", "content": "Neurosarcoidosis\u00a0may present as either a monophasic illness, a relapsing-remitting course, or as a progressive\u00a0disease with episodes of deterioration.\u00a0It\u00a0is not well known\u00a0what the\u00a0long-term\u00a0effects\u00a0of\u00a0neurosarcoidosis\u00a0are. Usually, patients with facial nerve palsy or other cranial mononeuropathies will improve. In contrast, cases with aseptic meningitis or meningeal/parenchymal mass lesions have a longer course. Hypothalamic vegetative symptoms rarely resolve although may respond to treatment.", "contents": "Neurosarcoidosis -- Prognosis. Neurosarcoidosis\u00a0may present as either a monophasic illness, a relapsing-remitting course, or as a progressive\u00a0disease with episodes of deterioration.\u00a0It\u00a0is not well known\u00a0what the\u00a0long-term\u00a0effects\u00a0of\u00a0neurosarcoidosis\u00a0are. Usually, patients with facial nerve palsy or other cranial mononeuropathies will improve. In contrast, cases with aseptic meningitis or meningeal/parenchymal mass lesions have a longer course. Hypothalamic vegetative symptoms rarely resolve although may respond to treatment."}
{"id": "article-25834_19", "title": "Neurosarcoidosis -- Prognosis", "content": "Encephalopathy/vasculopathy\u00a0tends\u00a0to\u00a0have a relapsing-remitting course with deterioration. Cases with hydrocephalus may either be asymptomatic or cause rapid deterioration. Facial palsy tends to improve over 4-6 weeks. The optic neuropathy may improve over a few weeks but in others, it may lead to blindness. Remissions are possible in peripheral neuropathy and myopathy cases,\u00a0however, the course usually is chronic and progressive.", "contents": "Neurosarcoidosis -- Prognosis. Encephalopathy/vasculopathy\u00a0tends\u00a0to\u00a0have a relapsing-remitting course with deterioration. Cases with hydrocephalus may either be asymptomatic or cause rapid deterioration. Facial palsy tends to improve over 4-6 weeks. The optic neuropathy may improve over a few weeks but in others, it may lead to blindness. Remissions are possible in peripheral neuropathy and myopathy cases,\u00a0however, the course usually is chronic and progressive."}
{"id": "article-25834_20", "title": "Neurosarcoidosis -- Pearls and Other Issues", "content": "With a diagnosis of sarcoidosis, physicians should be careful to monitor the signs and symptoms of\u00a0neurosarcoidosis, with the most common symptom being cranial neuropathy involving the facial nerve. However, although most cases\u00a0resolve,\u00a0it is important to provide\u00a0follow-up\u00a0care to monitor for evolving symptoms. Treatment involves steroids to stop the inflammatory response caused by systemic sarcoidosis.", "contents": "Neurosarcoidosis -- Pearls and Other Issues. With a diagnosis of sarcoidosis, physicians should be careful to monitor the signs and symptoms of\u00a0neurosarcoidosis, with the most common symptom being cranial neuropathy involving the facial nerve. However, although most cases\u00a0resolve,\u00a0it is important to provide\u00a0follow-up\u00a0care to monitor for evolving symptoms. Treatment involves steroids to stop the inflammatory response caused by systemic sarcoidosis."}
{"id": "article-25834_21", "title": "Neurosarcoidosis -- Enhancing Healthcare Team Outcomes", "content": "An interprofessional approach to neurosarcoidosis is recommended.", "contents": "Neurosarcoidosis -- Enhancing Healthcare Team Outcomes. An interprofessional approach to neurosarcoidosis is recommended."}
{"id": "article-25834_22", "title": "Neurosarcoidosis -- Enhancing Healthcare Team Outcomes", "content": "Cases of\u00a0neurosarcoidosis\u00a0require an interprofessional effort because the disorder has diverse presentations and has no specific test to make a diagnosis. Given the systemic involvement associated with\u00a0neurosarcoidosis,\u00a0a variety of specialists should be consulted\u00a0such as rheumatology, endocrinology, and pulmonology.\u00a0Neurosurgery may be consulted\u00a0as well for resection of CNS masses. However, biopsy/excision procedures that involve the CNS can be associated with severe consequences, and remain a treatment of last choice. Thus, resection should\u00a0be deferred, unless the mass continues to enlarge after immunosuppression. For cases with hydrocephalus, a\u00a0ventriculoperitoneal\u00a0shunt may be placed, albeit the risk of infection. Patients on prolonged steroids may benefit from a dietician consult to manage weight\u00a0gain\u00a0and\u00a0to develop an exercise program and reduce bone loss. All patients started on corticosteroids need to be monitored for adverse effects by the pharmacist. As soon as symptoms subside, rapid tapering of the drug is recommended. [11]", "contents": "Neurosarcoidosis -- Enhancing Healthcare Team Outcomes. Cases of\u00a0neurosarcoidosis\u00a0require an interprofessional effort because the disorder has diverse presentations and has no specific test to make a diagnosis. Given the systemic involvement associated with\u00a0neurosarcoidosis,\u00a0a variety of specialists should be consulted\u00a0such as rheumatology, endocrinology, and pulmonology.\u00a0Neurosurgery may be consulted\u00a0as well for resection of CNS masses. However, biopsy/excision procedures that involve the CNS can be associated with severe consequences, and remain a treatment of last choice. Thus, resection should\u00a0be deferred, unless the mass continues to enlarge after immunosuppression. For cases with hydrocephalus, a\u00a0ventriculoperitoneal\u00a0shunt may be placed, albeit the risk of infection. Patients on prolonged steroids may benefit from a dietician consult to manage weight\u00a0gain\u00a0and\u00a0to develop an exercise program and reduce bone loss. All patients started on corticosteroids need to be monitored for adverse effects by the pharmacist. As soon as symptoms subside, rapid tapering of the drug is recommended. [11]"}
{"id": "article-25834_23", "title": "Neurosarcoidosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Neurosarcoidosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}